A cross-sectional nationwide survey of adults in the USA in 2021. Records captures the rate of psychedelic use, comorbid conditions, mental and physical health, and factors predictive of psychedelic use were assessed.

Population Health Data Survey – Patient Reported Data

Data Challenge

Details

User consent

Yes

Records volume

7138

Data History

2021

Data Source

✔Other | Patient Reported Data

Prevalent Dx (diagnoses)

Depression; Anxiety; PTSD; Addiction; Chronic pain; Allergies; Migraines; Insomnia; Hypertension; Sleep apnea; Gastrointestinal; GERD

Prevalent Rx/Tx (Drug/treatment protocols)

Psylocibin (psychedelic mushrooms)

Combined (Tx) therapy

none

Data Features

✔Active diagnosis (Dx), Co-Morbidities (Preexisting conditions, other active diagnoses the patient has, historical Dx), Risk Factors, Allergies, Side Effects/ADR, Encounters/Appointments history, Medications(Rx=Prescribed Drugs), CoC Meds(additional drugs/combinations), PRO (Patient Reported outcomes), Life Style/Reported habits, Survey

Additional Data Features

Morlock​,​ Robert (2021)​,​ Data from: Psychedelic mushrooms in the USA: knowledge​,​ patterns of use​,​ and association with health outcomes​,​ Dryad​,​ Dataset​,​ https://doi.org/10.5061/dryad.bzkh189b6

Source

88la